Poland· PL-100375949
Rhesonativ
A anti-d (rh) immunoglobulin product containing immunoglobulinum humanum anti-d, registered in Poland by Octapharma (IP) SPRL. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Anti-d (rh) immunoglobulin is registered in 11 of 19 countries.
Countries holding a registration under ATC J06BB01 (anti-d (rh) immunoglobulin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Anti-d (rh) immunoglobulin · ATC J06BB01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Immunoglobulinum humanum anti-D
- Manufacturer
- Octapharma (IP) SPRL
- Country
- Poland (PL)
- ATC code
- J06BB01
- ATC class
- Anti-D (rh) immunoglobulin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991353964
- gtin05909991353971
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Anti-d (rh) immunoglobulin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainIGAMAD 750 UI/ml SOLUCION INYECTABLE EN JERINGA PRECARGADAInstituto Grifols S.A.
- NorwayRhophylacCSL Behring GmbH
- SwedenRhesonativ 750 IE/ml Injektionsvätska, lösningOctapharma AB
- United KingdomAnti-D (RHO) immunoglobulin 1,250units/1ml solution for injection pre-filled syringesBaxter Healthcare Ltd
- FinlandRhesonativOctapharma Ab
- United StatesHYPERRHOGRIFOLS USA, LLC
- NetherlandsRhesonativ 625 IE/ml, oplossing voor injectieOctapharma GmbH
- BelgiumImmunorho 300 µg/2 mlKedrion
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Rhesonativ, Rhophylac
- Belgium · Immunorho, Rhophylac
- Bulgaria · Резонатив
- Cyprus · Rhesonativ, Rhophylac
- Czechia · Igamad, Rhesonativ
- Germany · Rhesonativ, Rhophylac
- Denmark · Rhesonativ, Rhophylac
- Estonia · Rhesonativ
- Spain · Igamad, Rhophylac
- Finland · Rhophylac
- France · Rhesonativ, Rhophylac
- United Kingdom (Northern Ireland) · D-Gam, Rhophylac
- Greece · Rhophylac
- Hungary · Rhesonativ, Rhophylac
- Ireland · Rhophylac
- Iceland · Rhesonativ, Rhophylac
- Italy · Igamad, Immunorho
- Lithuania · Rhesonativ
- Luxembourg · Rhesonativ, Rhophylac
- Latvia · Rhesonativ
- Malta · Rhesonativ, Rhophylac
- Netherlands · Rhesonativ, Rhophylac
- Norway · Rhesonativ, Rhophylac
- Portugal · Rhesonativ, Rhophylac
- Romania · Rhesonativ, Rhophylac
- Sweden · Rhesonativ, Rhophylac
- Slovenia · Rhesonativ, Rhophylac
- Slovakia · Igamad, Rhesonativ
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b92e428d-43f8-42d7-8b93-2b149b7df3f3 GET /v1/drugs/b92e428d-43f8-42d7-8b93-2b149b7df3f3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "750 IU/ml",
"packaging": "05909991353964 ¦ Rpz ¦ 125464\n1 amp. 2 ml\n05909991353971 ¦ Rpz ¦ 125465\n1 amp. 1 ml",
"substance": "Immunoglobulinum humanum anti-D 750 IU/ml",
"common_name": "Immunoglobulinum humanum anti-D",
"pl_product_id": "100375949",
"pozwolenie_nr": "24406",
"auth_procedure": "DCP",
"authorisation_validity": "2025-12-09"
}See everything about anti-d (rh) immunoglobulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.